Cargando…
Bepridil is potent against SARS-CoV-2 in vitro
Guided by a computational docking analysis, about 30 Food and Drug Administration/European Medicines Agency (FDA/EMA)-approved small-molecule medicines were characterized on their inhibition of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease (M(p)(ro)). Of these small...
Autores principales: | Vatansever, Erol C., Yang, Kai S., Drelich, Aleksandra K., Kratch, Kaci C., Cho, Chia-Chuan, Kempaiah, Kempaiah Rayavara, Hsu, Jason C., Mellott, Drake M., Xu, Shiqing, Tseng, Chien-Te K., Liu, Wenshe Ray |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958448/ https://www.ncbi.nlm.nih.gov/pubmed/33597253 http://dx.doi.org/10.1073/pnas.2012201118 |
Ejemplares similares
-
Bepridil is potent against SARS-CoV-2 In Vitro
por: Vatansever, Erol C., et al.
Publicado: (2020) -
Efficacy and self-similarity of SARS-CoV-2 thermal decontamination
por: Yap, Te Faye, et al.
Publicado: (2022) -
Proteolysis at a Specific Extracellular Residue Implicates Integral Membrane CLAG3 in Malaria Parasite Nutrient Channels
por: Nguitragool, Wang, et al.
Publicado: (2014) -
Self-Masked Aldehyde Inhibitors of Human Cathepsin L Are Potent Anti-CoV-2 Agents
por: Zhu, Jiyun, et al.
Publicado: (2022) -
Bepridil Might be Potent Against the Coronavirus Disease 2019–related Electrical Storm in Brugada Syndrome
por: Higaki, Akinori
Publicado: (2022)